导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 59.23% | 21/1050 |
| 近一周 | -3.59% | 922/1104 |
| 近一月 | -6.74% | 808/1102 |
| 近一季 | -17.89% | 1003/1092 |
| 近半年 | 24.80% | 104/1070 |
| 近一年 | 77.45% | 16/1018 |
| 近两年 | 349.99% | 3/926 |
| 近三年 | 242.45% | 8/833 |
| 成立以来 | 567.70% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
23.31% 6/1070 |
97.52% 53/1101 |
- - |
- - |
| 2025 | 104.91% 4/1065 |
9.46% 163/1014 |
6.48% 214/1038 |
61.15% 37/1050 |
9.10% 56/1065 |
| 2024 | 18.58% 106/1011 |
2.94% 167/960 |
-2.69% 480/983 |
9.09% 702/991 |
8.51% 78/1011 |
| 2023 | -36.99% 840/952 |
-6.77% 823/880 |
-2.39% 334/895 |
-21.48% 875/915 |
-11.82% 898/952 |
| 2022 | -19.14% 297/867 |
-20.10% 520/773 |
24.15% 3/806 |
-16.41% 644/845 |
-2.48% 558/867 |
| 2021 | 29.74% 73/740 |
-10.85% 506/580 |
30.91% 51/659 |
11.03% 52/704 |
0.13% 434/740 |
| 2020 | 111.36% 16/554 |
0.82% 146/419 |
33.37% 88/466 |
15.56% 136/517 |
36.01% 21/554 |
| 2019 | 63.07% 67/410 |
20.86% 899/1146 |
-5.37% 733/1228 |
23.65% 9/390 |
15.32% 49/410 |
| 2018 | - - |
- - |
- - |
- - |
-5.50% 67/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 红土创新新科技股票 VS. 东吴新产业精选股票A(580008) |